Arcutis Biotherapeutics, Inc. ARQT Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s current ratio?
- Arcutis Biotherapeutics, Inc. (ARQT) reported current ratio of 2.7× in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s current ratio changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s current ratio decreased by 24.4% year-over-year, from 3.6× to 2.7×.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s current ratio has grown at a -24.6% compound annual growth rate (CAGR), from 13× to 3.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.